Xiao-Bo Chen Selected Research

Xiao-Bo Chen Research Topics

Disease

6	Neoplasms (Cancer) 05/2021 - 07/2008
3	Infections 01/2022 - 11/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 06/2010
2	Pathologic Constriction (Stenosis) 05/2021 - 01/2021
2	Tuberculosis (Tuberculoses) 01/2021 - 11/2009
2	Tracheal Stenosis 01/2021 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2017 - 01/2017
2	Adenocarcinoma of Lung 01/2017 - 02/2016
2	Fibrosis (Cirrhosis) 05/2014 - 07/2012
1	Airway Remodeling 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Patent Ductus Arteriosus 01/2022
1	Heart Failure 01/2022
1	Fistula 05/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Emergence Delirium 11/2019
1	Hemolysis 10/2019
1	Hepatitis B 01/2018
1	Body Weight (Weight, Body) 05/2014
1	Liver Failure 05/2014
1	Primary Graft Dysfunction 04/2014
1	Diarrhea 02/2013
1	Insulinoma 08/2012
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2012
1	Hypoxia (Hypoxemia) 06/2010
1	Carcinogenesis 06/2010
1	Pulmonary Tuberculosis 11/2009
1	Retinoblastoma (Glioblastoma, Retinal) 07/2008
1	Pulmonary Hypertension 02/2004
1	Hypertension (High Blood Pressure) 02/2004

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 07/2012 - 07/2008
2	MagnesiumIBA 01/2022 - 11/2019
2	GalliumIBA 01/2022 - 11/2019
2	SiliconesIBA 05/2021 - 01/2021
2	AlloysIBA 11/2019 - 10/2019
2	MicroRNAs (MicroRNA)IBA 01/2017 - 02/2016
1	strontium phosphateIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	MB Form Creatine KinaseIBA 01/2022
1	IonsIBA 01/2022
1	SiliconIBA 05/2021
1	MetalsIBA 05/2021
1	benzoyltyrosine 4-nitroanilideIBA 01/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 11/2019
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 11/2019
1	Biocompatible Materials (Biomaterials)IBA 11/2019
1	StrontiumIBA 11/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 10/2019
1	HydrogenIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Hepatitis B e AntigensIBA 01/2018
1	PolyelectrolytesIBA 01/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2017
1	Ether (Diethyl Ether)IBA 01/2017
1	SolutionsIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Prostaglandins DIBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2012
1	E-SelectinIBA 07/2012
1	CD40 Ligand (CD40L)IBA 07/2012
1	Caspase 8 (Caspase-8)IBA 07/2012
1	EP1 Subtype Prostaglandin E ReceptorsIBA 06/2010
1	Prostaglandins EIBA 06/2010
1	Phosphotransferases (Kinase)IBA 06/2010
1	Ribosomal Protein S6IBA 06/2010
1	Pertussis ToxinIBA 06/2010
1	platelet protein P47 (pleckstrin)IBA 11/2009
1	A-Form DNA (A-DNA)IBA 07/2008
1	Transcription Factors (Transcription Factor)IBA 07/2008
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2008
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2004
1	Messenger RNA (mRNA)IBA 02/2004

Therapy/Procedure

3	Stents 05/2021 - 01/2021
3	Liver Transplantation 04/2014 - 01/2012
2	Anesthesia 11/2019 - 01/2017
2	Hepatectomy 01/2017 - 05/2014
1	Ligation 01/2022
1	Palliative Care (Palliative Therapy) 05/2021
1	Radiofrequency Ablation 01/2021
1	Photochemotherapy (Photodynamic Therapy) 10/2020
1	Quantum Dots (Quantum Dot) 01/2018
1	Intraperitoneal Injections 01/2017
1	Length of Stay 05/2014
1	Moxibustion 02/2013